Maxigen Biotech Inc. (TPE:1783)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
44.30
+0.30 (0.68%)
At close: Feb 11, 2026

Maxigen Biotech Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3,5754,3654,3044,0363,9961,591
Market Cap Growth
-21.39%1.40%6.65%0.99%151.22%-9.31%
Enterprise Value
2,8433,8213,8843,3243,5341,454
Last Close Price
44.3048.0346.4743.2042.7718.66
PE Ratio
17.1022.9525.9628.9545.5925.13
Forward PE
-10.5310.5310.5310.5310.53
PS Ratio
4.516.416.926.687.813.48
PB Ratio
2.433.173.163.123.501.85
P/TBV Ratio
2.433.173.163.123.511.85
P/FCF Ratio
15.9916.3828.9415.8938.6724.92
P/OCF Ratio
12.9114.6425.1415.0433.9821.33
EV/Sales Ratio
3.595.616.245.506.903.18
EV/EBITDA Ratio
10.6018.4821.9421.2129.5115.95
EV/EBIT Ratio
11.9121.2425.9225.8439.2823.80
EV/FCF Ratio
12.7214.3426.1113.0834.2022.79
Debt / Equity Ratio
----0.010.01
Debt / EBITDA Ratio
----0.080.13
Debt / FCF Ratio
----0.090.19
Net Debt / Equity Ratio
-0.50-0.46-0.32-0.62-0.45-0.23
Net Debt / EBITDA Ratio
-2.72-3.09-2.43-5.10-4.32-2.17
Net Debt / FCF Ratio
-3.27-2.40-2.90-3.15-5.01-3.10
Asset Turnover
0.490.440.420.450.460.43
Inventory Turnover
3.102.452.462.952.982.76
Quick Ratio
3.773.614.025.945.533.60
Current Ratio
4.194.034.726.566.754.99
Return on Equity (ROE)
16.67%13.90%12.48%11.44%8.76%7.40%
Return on Assets (ROA)
9.21%7.31%6.37%5.93%5.06%3.57%
Return on Invested Capital (ROIC)
29.04%18.21%18.05%19.31%12.57%7.62%
Return on Capital Employed (ROCE)
16.10%13.10%11.00%9.90%7.80%7.00%
Earnings Yield
6.55%4.36%3.85%3.45%2.19%3.98%
FCF Yield
6.25%6.11%3.46%6.30%2.59%4.01%
Dividend Yield
1.87%1.73%2.15%1.10%-3.39%
Payout Ratio
31.80%46.78%25.54%-64.18%85.58%
Buyback Yield / Dilution
-0.62%-0.27%-0.07%-5.78%-4.81%8.21%
Total Shareholder Return
1.25%1.46%2.08%-4.68%-4.81%11.59%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.